Oligella species are rare bacterium documented in Brazil, India, and Nigeria that causes human infections. It primarily affects in individuals with weakened immunity, diabetes, and kidney problems.
An adult patient in India was diagnosed for lung cancer. The patient was reported to develop high carbon dioxide levels and abnormal blood flow with rapid heart rate. O. urethralis prevalence is hard to track because of improper surveillance and it is misidentified in clinical studies.
O. urethralis is a species in the Oligella genus belonging to the Burkholderiales and Alcaligenaceae. It has rod-shaped morphology, oxidase-positive and a nonfermentative bacterium.
Visually, it appears as small rod-shaped cells, rarely exceeding one micron long. These tiny rods often occur in pairs, forming compact bacterial couples.
The cell membrane has peptidoglycan layers. It consists phospholipid chains bonding in outer walls. It does not synthesize capsule or spores structures.
Oligella urethralis has distinct traits making it harmful and easy to identify. It has urease activity, breaking down urea and making urine alkaline. This alkalinity causes phosphate deposition, forming stones and impacting urinary health.
The 16S rRNA sequence of O. urethralis concluded 97.5% identity with ureolytica species. The similarity criteria belong to their genetic relationship. The methods like 16S rRNA gene sequencing are used in identification. O. urethralis type strain is MC213, and cataloged in various culture collections, including ATCC 17960, JCM 20913, and NCTC 12964.
Several factors may contribute to Oligella bacterium’s harmful effects. These include ability to adhere to cells, form biofilms, produce urease, and resist host defenses.
Oligella urethralis transmission occurs through sexual contact or contaminated medical devices like dialysis solutions, urinary catheters, and blood products. Its presence in the genitourinary tract links to sexual transmission risk.
Oligella urethralis infections causes unique pathological effects, it depends on the infection severity. Potential outcomes seen in patients are abscess formation and systemic complications.
Oligellaurethralis is primarily relying on the innate immune response with many barriers, cellular components, and soluble factors. Cytokines causes inflammation with antimicrobial peptides targeting Oligella by disrupting their membrane and metabolism.
Natural killer cells lyse O. urethralis and infected cells through perforins and granzymes while soluble factors like the complement system, cytokines, and antimicrobial peptides enhance host defenses.
The urinary tract has special defenses against O. urethralis. Urine flow, pH, and osmolality that make an environment condition unfavorable for the bacteria’s growth. Normal flora like lactobacilli compete with O. urethralis for nutrients.
Oligella urethralis cause infections in body parts like joints, and peritoneum. This pathogen is reported in serious diseases like urosepsis, a severe urinary tract infection that spreads to the bloodstream. Symptoms of Oligella urethralis infections are fever pus and swelling in the infected area.
Oligella urethralis causes spinal cord infections, pneumonia, and heart valve diseases in immune deficient individuals. Healthcare workers must consider O. urethralis as a possible cause of genitourinary tract infections.
Culturing the organism is initiated by sampling from the affected area and fluid samples. The positive samples obtained are used in subculturing on selective media like Columbia agar, MacConkey agar, and Chocolate agar with PolyViteX. The cultures are incubated for 48 hours at optimum temperature.
16S rRNA gene sequencing and Mass spectrometry is used for the accurate identification. These methods give higher specificity in distinguishing Oligella urethralis from other strains.
Antimicrobial susceptibility provides effective drug results for treatment decision making. Some Oligella strains showed resistance to ciprofloxacin drug. So, the targeted drug testing gives appropriate results and efficacious antimicrobial agents for optimal patient outcome.
Replace urinary catheters or drainage systems regularly. Monitor to alkalization of urine pH that supports pathogen growth and stone formation.
Keep medical equipment and devices disinfected before utilizing it. Instructions by manufacturer on label must be followed.
When inserting or changing urinary catheters, use aseptic and sterile techniques.
Oligella species are rare bacterium documented in Brazil, India, and Nigeria that causes human infections. It primarily affects in individuals with weakened immunity, diabetes, and kidney problems.
An adult patient in India was diagnosed for lung cancer. The patient was reported to develop high carbon dioxide levels and abnormal blood flow with rapid heart rate. O. urethralis prevalence is hard to track because of improper surveillance and it is misidentified in clinical studies.
O. urethralis is a species in the Oligella genus belonging to the Burkholderiales and Alcaligenaceae. It has rod-shaped morphology, oxidase-positive and a nonfermentative bacterium.
Visually, it appears as small rod-shaped cells, rarely exceeding one micron long. These tiny rods often occur in pairs, forming compact bacterial couples.
The cell membrane has peptidoglycan layers. It consists phospholipid chains bonding in outer walls. It does not synthesize capsule or spores structures.
Oligella urethralis has distinct traits making it harmful and easy to identify. It has urease activity, breaking down urea and making urine alkaline. This alkalinity causes phosphate deposition, forming stones and impacting urinary health.
The 16S rRNA sequence of O. urethralis concluded 97.5% identity with ureolytica species. The similarity criteria belong to their genetic relationship. The methods like 16S rRNA gene sequencing are used in identification. O. urethralis type strain is MC213, and cataloged in various culture collections, including ATCC 17960, JCM 20913, and NCTC 12964.
Several factors may contribute to Oligella bacterium’s harmful effects. These include ability to adhere to cells, form biofilms, produce urease, and resist host defenses.
Oligella urethralis transmission occurs through sexual contact or contaminated medical devices like dialysis solutions, urinary catheters, and blood products. Its presence in the genitourinary tract links to sexual transmission risk.
Oligella urethralis infections causes unique pathological effects, it depends on the infection severity. Potential outcomes seen in patients are abscess formation and systemic complications.
Oligellaurethralis is primarily relying on the innate immune response with many barriers, cellular components, and soluble factors. Cytokines causes inflammation with antimicrobial peptides targeting Oligella by disrupting their membrane and metabolism.
Natural killer cells lyse O. urethralis and infected cells through perforins and granzymes while soluble factors like the complement system, cytokines, and antimicrobial peptides enhance host defenses.
The urinary tract has special defenses against O. urethralis. Urine flow, pH, and osmolality that make an environment condition unfavorable for the bacteria’s growth. Normal flora like lactobacilli compete with O. urethralis for nutrients.
Oligella urethralis cause infections in body parts like joints, and peritoneum. This pathogen is reported in serious diseases like urosepsis, a severe urinary tract infection that spreads to the bloodstream. Symptoms of Oligella urethralis infections are fever pus and swelling in the infected area.
Oligella urethralis causes spinal cord infections, pneumonia, and heart valve diseases in immune deficient individuals. Healthcare workers must consider O. urethralis as a possible cause of genitourinary tract infections.
Culturing the organism is initiated by sampling from the affected area and fluid samples. The positive samples obtained are used in subculturing on selective media like Columbia agar, MacConkey agar, and Chocolate agar with PolyViteX. The cultures are incubated for 48 hours at optimum temperature.
16S rRNA gene sequencing and Mass spectrometry is used for the accurate identification. These methods give higher specificity in distinguishing Oligella urethralis from other strains.
Antimicrobial susceptibility provides effective drug results for treatment decision making. Some Oligella strains showed resistance to ciprofloxacin drug. So, the targeted drug testing gives appropriate results and efficacious antimicrobial agents for optimal patient outcome.
Replace urinary catheters or drainage systems regularly. Monitor to alkalization of urine pH that supports pathogen growth and stone formation.
Keep medical equipment and devices disinfected before utilizing it. Instructions by manufacturer on label must be followed.
When inserting or changing urinary catheters, use aseptic and sterile techniques.
Oligella species are rare bacterium documented in Brazil, India, and Nigeria that causes human infections. It primarily affects in individuals with weakened immunity, diabetes, and kidney problems.
An adult patient in India was diagnosed for lung cancer. The patient was reported to develop high carbon dioxide levels and abnormal blood flow with rapid heart rate. O. urethralis prevalence is hard to track because of improper surveillance and it is misidentified in clinical studies.
O. urethralis is a species in the Oligella genus belonging to the Burkholderiales and Alcaligenaceae. It has rod-shaped morphology, oxidase-positive and a nonfermentative bacterium.
Visually, it appears as small rod-shaped cells, rarely exceeding one micron long. These tiny rods often occur in pairs, forming compact bacterial couples.
The cell membrane has peptidoglycan layers. It consists phospholipid chains bonding in outer walls. It does not synthesize capsule or spores structures.
Oligella urethralis has distinct traits making it harmful and easy to identify. It has urease activity, breaking down urea and making urine alkaline. This alkalinity causes phosphate deposition, forming stones and impacting urinary health.
The 16S rRNA sequence of O. urethralis concluded 97.5% identity with ureolytica species. The similarity criteria belong to their genetic relationship. The methods like 16S rRNA gene sequencing are used in identification. O. urethralis type strain is MC213, and cataloged in various culture collections, including ATCC 17960, JCM 20913, and NCTC 12964.
Several factors may contribute to Oligella bacterium’s harmful effects. These include ability to adhere to cells, form biofilms, produce urease, and resist host defenses.
Oligella urethralis transmission occurs through sexual contact or contaminated medical devices like dialysis solutions, urinary catheters, and blood products. Its presence in the genitourinary tract links to sexual transmission risk.
Oligella urethralis infections causes unique pathological effects, it depends on the infection severity. Potential outcomes seen in patients are abscess formation and systemic complications.
Oligellaurethralis is primarily relying on the innate immune response with many barriers, cellular components, and soluble factors. Cytokines causes inflammation with antimicrobial peptides targeting Oligella by disrupting their membrane and metabolism.
Natural killer cells lyse O. urethralis and infected cells through perforins and granzymes while soluble factors like the complement system, cytokines, and antimicrobial peptides enhance host defenses.
The urinary tract has special defenses against O. urethralis. Urine flow, pH, and osmolality that make an environment condition unfavorable for the bacteria’s growth. Normal flora like lactobacilli compete with O. urethralis for nutrients.
Oligella urethralis cause infections in body parts like joints, and peritoneum. This pathogen is reported in serious diseases like urosepsis, a severe urinary tract infection that spreads to the bloodstream. Symptoms of Oligella urethralis infections are fever pus and swelling in the infected area.
Oligella urethralis causes spinal cord infections, pneumonia, and heart valve diseases in immune deficient individuals. Healthcare workers must consider O. urethralis as a possible cause of genitourinary tract infections.
Culturing the organism is initiated by sampling from the affected area and fluid samples. The positive samples obtained are used in subculturing on selective media like Columbia agar, MacConkey agar, and Chocolate agar with PolyViteX. The cultures are incubated for 48 hours at optimum temperature.
16S rRNA gene sequencing and Mass spectrometry is used for the accurate identification. These methods give higher specificity in distinguishing Oligella urethralis from other strains.
Antimicrobial susceptibility provides effective drug results for treatment decision making. Some Oligella strains showed resistance to ciprofloxacin drug. So, the targeted drug testing gives appropriate results and efficacious antimicrobial agents for optimal patient outcome.
Replace urinary catheters or drainage systems regularly. Monitor to alkalization of urine pH that supports pathogen growth and stone formation.
Keep medical equipment and devices disinfected before utilizing it. Instructions by manufacturer on label must be followed.
When inserting or changing urinary catheters, use aseptic and sterile techniques.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
